Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on March 9, 2021.
July 02, 2021 at 02:30 am EDT
Share
From April 1, 2021 to June 30, 2021, the company has repurchased 188,475 shares, representing 0.36% for KRW 14,441.43 million. With this, the company has completed the repurchase of 188,475 shares, representing 0.36% for KRW 14,441.43 million under the buyback announced on March 9, 2021.
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.
SEEGENE, INC. 
